Literature DB >> 18363898

Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease.

O Chassany1, G Holtmann, J Malagelada, U Gebauer, H Doerfler, K Devault.   

Abstract

BACKGROUND: Although gastro-oesophageal reflux disease (GERD) has a well-established pathophysiology, the impact of GERD symptoms on the patients' quality of life can be profound. Therefore, health-related quality of life (HRQOL) questionnaires have become standard instruments to evaluate the effect of treatment in clinical trials. AIM: To evaluate the reliability, validity and responsiveness of available GERD-specific HRQOL.
METHODS: A systematic literature search using the Medical Subject Headings terms: 'Gastro-oesophageal reflux', 'Heartburn' and 'Oesophagitis' with 'quality of life' and 'questionnaires' was preformed to identify the available HRQOL questionnaires. To analyse the psychometric properties of the respective tools, the actual guidelines for the use of patient-reported outcomes in clinical trials were applied.
RESULTS: We identified five GERD-specific HRQOL questionnaires but none of them fulfilled all quality criteria; either they did not meet the actual standards for psychometric properties (HBQOL, GERD-HRQL, Jasani et al.Aust Fam Physician 1999; 28: 515), or were impracticable to use in clinical trials. The generic and hybrid instruments lack specificity and sensitivity and were not designed for treatment evaluation in GERD patients.
CONCLUSION: There is need for a new evaluative tool in the assessment of HRQOL during GERD therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18363898     DOI: 10.1111/j.1365-2036.2008.03683.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  Predicting physical quality of life among a multiethnic sample of breast cancer survivors.

Authors:  Kimlin T Ashing-Giwa; Jung-Won Lim
Journal:  Qual Life Res       Date:  2010-03-27       Impact factor: 4.147

2.  Surgical cure of primary hyperparathyroidism ameliorates gastroesophageal reflux symptoms.

Authors:  James Norman; Douglas Politz; Jose Lopez; Deva Boone; Alexander Stojadinovic
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

3.  A Review of New Surgical and Endoscopic Therapies for Gastroesophageal Reflux Disease.

Authors:  Robert A Ganz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-07

4.  The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting.

Authors:  N A Koloski; M Jones; J Hammer; M von Wulffen; A Shah; H Hoelz; M Kutyla; D Burger; N Martin; S R Gurusamy; N J Talley; G Holtmann
Journal:  Dig Dis Sci       Date:  2017-05-27       Impact factor: 3.199

Review 5.  Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.

Authors:  Y Claire Dorsey; Erin J Song; David A Leiman
Journal:  Curr Gastroenterol Rep       Date:  2021-12-01

6.  A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease.

Authors:  Jung Ho Park; Hyojin Park; Dong Ho Lee; In Kyung Sung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

7.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

8.  Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study.

Authors:  Umberto Alecci; Francesco Bonina; Andrea Bonina; Luisa Rizza; Santi Inferrera; Carmen Mannucci; Gioacchino Calapai
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-12       Impact factor: 2.629

9.  Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Journal:  Health Qual Life Outcomes       Date:  2009-07-02       Impact factor: 3.186

Review 10.  Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures.

Authors:  Emmanuelle Anthoine; Leïla Moret; Antoine Regnault; Véronique Sébille; Jean-Benoit Hardouin
Journal:  Health Qual Life Outcomes       Date:  2014-12-09       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.